SG Americas Securities’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $107K | Buy |
94,717
+56,255
| +146% | +$63.6K | ﹤0.01% | 2314 |
|
|
2025
Q1 | $56K | Sell |
38,462
-11,472
| -23% | -$16.7K | ﹤0.01% | 2829 |
|
|
2024
Q4 | $106K | Buy |
49,934
+2,967
| +6% | +$6.3K | ﹤0.01% | 2411 |
|
|
2024
Q3 | $132K | Buy |
46,967
+33,651
| +253% | +$94.6K | ﹤0.01% | 2516 |
|
|
2024
Q2 | $31K | Sell |
13,316
-21,842
| -62% | -$50.8K | ﹤0.01% | 2356 |
|
|
2024
Q1 | $157K | Sell |
35,158
-18,326
| -34% | -$81.8K | ﹤0.01% | 1923 |
|
|
2023
Q4 | $172K | Buy |
+53,484
| New | +$172K | ﹤0.01% | 2093 |
|
|
2023
Q2 | – | Sell |
-16,172
| Closed | -$80K | – | 1930 |
|
|
2023
Q1 | $80K | Buy |
16,172
+4,400
| +37% | +$21.8K | ﹤0.01% | 2712 |
|
|
2022
Q4 | $74K | Buy |
11,772
+328
| +3% | +$2.06K | ﹤0.01% | 2522 |
|
|
2022
Q3 | $124K | Sell |
11,444
-61,063
| -84% | -$662K | ﹤0.01% | 2400 |
|
|
2022
Q2 | $827K | Sell |
72,507
-107,111
| -60% | -$1.22M | 0.01% | 1318 |
|
|
2022
Q1 | $1.64M | Buy |
179,618
+55,994
| +45% | +$510K | 0.01% | 923 |
|
|
2021
Q4 | $1.84M | Buy |
123,624
+24,770
| +25% | +$369K | 0.01% | 1042 |
|
|
2021
Q3 | $2.54M | Buy |
98,854
+20,440
| +26% | +$525K | 0.01% | 952 |
|
|
2021
Q2 | $2.05M | Sell |
78,414
-3,592
| -4% | -$93.7K | 0.01% | 1007 |
|
|
2021
Q1 | $2.9M | Sell |
82,006
-21,702
| -21% | -$766K | 0.02% | 715 |
|
|
2020
Q4 | $2.62M | Buy |
103,708
+80,444
| +346% | +$2.03M | 0.01% | 792 |
|
|
2020
Q3 | $877K | Sell |
23,264
-7,168
| -24% | -$270K | 0.01% | 1047 |
|
|
2020
Q2 | $1.3M | Sell |
30,432
-21,676
| -42% | -$928K | 0.01% | 949 |
|
|
2020
Q1 | $1.01M | Buy |
52,108
+29,411
| +130% | +$572K | 0.01% | 1019 |
|
|
2019
Q4 | $590K | Sell |
22,697
-15,673
| -41% | -$407K | 0.01% | 1416 |
|
|
2019
Q3 | $1.05M | Buy |
+38,370
| New | +$1.05M | 0.01% | 1210 |
|